SF Prep Notes

First ICMR Annual Clinical Trial Meet: Ayurvedic anaemia trial results, Phase 1 report and single ethics review guidelines

At the 1st ICMR Annual Clinical Trial Meet on 20 May 2026, ICMR presented an ICMR-CCRAS anaemia trial, launched a report on First-in-Human Phase 1 trials and released guidelines for single ethics review of multicentre research.

Summary

The Indian Council of Medical Research (ICMR) held its 1st Annual Clinical Trial Meet on 20 May 2026 under the theme 'International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials'. Findings were presented from an ICMR-CCRAS multicentre Phase III randomised controlled trial of nearly 4,000 non-pregnant women aged 18–49 with moderate anaemia. The trial found Punarnavadi Mandura, alone and with Drakshavaleha, therapeutically equivalent to standard iron-folic acid over 90 days. ICMR launched a report, 'Advancing First-in-Human Phase 1 Clinical Trials in India: A Delphi Study on Regulatory Pathways and Opportunities', based on two rounds of consultation with 37 experts. ICMR also released the 'Operational Guidelines for Single Ethics Review of Multicentre Research in India'.

Key facts

Event / date
1st ICMR Annual Clinical Trial Meet, 20 May 2026
Theme
International Clinical Trials Day: Focus on Integrative Medicine Clinical Trials
Anaemia RCT
ICMR-CCRAS Phase III; ~4,000 non-pregnant women aged 18–49; 90 days
Result
Punarnavadi Mandura (alone / with Drakshavaleha) equivalent to iron-folic acid
Report
First-in-Human Phase 1 trials Delphi study; 37 experts, two rounds
Guidelines
Single Ethics Review of Multicentre Research in India

Practice MCQs 3 questions

Q1 Advanced

In the ICMR-CCRAS Phase III trial presented in May 2026, Punarnavadi Mandura was compared with which standard therapy for anaemia?

Show answer

Correct answer: C — Iron Folic Acid supplementation

The trial compared Punarnavadi Mandura, alone and with Drakshavaleha, against standard Iron Folic Acid supplementation and found them therapeutically equivalent.

Q2 Advanced

The ICMR report on First-in-Human Phase 1 clinical trials, launched in May 2026, was based on what kind of study?

Show answer

Correct answer: A — A Delphi study with 37 experts

The report is 'A Delphi Study on Regulatory Pathways and Opportunities', developed through two rounds of consultation with 37 experts.

Q3 Advanced

Consider the following statements about the 1st ICMR Annual Clinical Trial Meet (May 2026): 1. The anaemia trial enrolled pregnant women in their second trimester. 2. ICMR released Operational Guidelines for Single Ethics Review of Multicentre Research in India. Which of the statements given above is/are correct?

Show answer

Correct answer: B — 2 only

Statement 1 is wrong: the trial enrolled nearly 4,000 non-pregnant women aged 18–49 with moderate anaemia. Statement 2 is correct.

← All current affairs